Breaking News

Merck KGaA, Maker of Erbitux Cancer Drug, to Acquire Sigma-Aldrich for $17 Billion
Tweet TWEET

J&J Recalls Some Children’s Tylenol in South Korea

Johnson & Johnson (JNJ) said its South Korea unit recalled some children’s Tylenol after discovering that bottles contained too much of the medicine.

The company withdrew Children’s Dye-Free Tylenol Suspension -- Cherry Flavor in 100 milligram and 500 milligram bottles, said Samantha Lucas, a spokeswoman for New Brunswick, New Jersey-based J&J. Some bottles were found during quality-control tests to have too much acetaminophen, the active ingredient in the drug, she said.

J&J, the world’s biggest maker of health-care products, has faced production issues since 2010, including a U.S. recall of over-the-counter medicines such as children’s Tylenol. As a result, the company closed a factory and signed a consent decree with U.S. regulators to oversee some manufacturing. A variety of other products, including blood-sugar meters, metal hip implants and a bone putty used to stop bleeding, also have been recalled.

The recall in South Korea was announced April 23, Lucas said.

To contact the reporter on this story: Elizabeth Lopatto in San Francisco at elopatto@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.